|
|
||||||||
Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Abstract
Cobra factor, a protein of the venom of Naja naja, was isolated. It was characterized as a glycoprotein with a molecular weight of 144,000 and an electrophoretic mobility of a
globulin at pH 8.6. Added to whole human serum it converted and inactivated C3. The effect on C3 was found to be dependent upon a non-complement plasma protein and on bivalent cations. To generate C3-directed enzymatic activity, cobra factor had to enter into a firm complex with the plasma protein, a 5S thermolabile
pseudoglobulin.
Footnotes
1 This is publication number 509 from the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037.
2 This work was supported by United States Public Health Service Grant AI-07007 and United States Atomic Energy Commission Contract AT(04-3)-730.
This article has been cited by other articles:
![]() |
J. Kolln, E. Spillner, J. Andra, K. Klensang, and R. Bredehorst Complement Inactivation by Recombinant Human C3 Derivatives J. Immunol., November 1, 2004; 173(9): 5540 - 5545. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rawal and M. K. Pangburn Functional Role of the Noncatalytic Subunit of Complement C5 Convertase J. Immunol., February 1, 2000; 164(3): 1379 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |